Full text

Turn on search term navigation

Copyright © 2025, Saner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Parvimonas micra is an opportunistic oral pathogen; it is a fastidious gram-positive anaerobic organism that has been rarely associated with periprosthetic joint infections (PJIs). Owing to its slow growth and tendency to form biofilms, the organism often eludes conventional diagnostic approaches. We present a case of culture-negative PJI following multiple revision total knee arthroplasties, which was masked by calcium pyrophosphate deposition (CPPD) disease. Despite multiple negative cultures and empirical treatment, the patient experienced persistent symptoms and prosthetic loosening. Definitive diagnosis was only achieved through polymerase chain reaction (PCR) of periprosthetic tissue, which identified P. micra as the causative organism. Following the complete exchange of foreign material and targeted antimicrobial therapy, the patient experienced a full recovery, with symptom improvement and restoration of joint function. This case highlights the importance of molecular diagnostics in suspected PJI when cultures are repeatedly negative, particularly in the context of coexisting inflammatory conditions, such as CPPD. PCR and, when necessary, next-generation sequencing should be integral tools in the diagnostic algorithm for complex culture-negative PJIs.

Details

Title
Concurrent Pseudogout and Parvimonas micra Prosthetic Joint Infection: Polymerase Chain Reaction (PCR) Can Be the Key to Success
Author
Saner, Markus 1 ; Julian, Claas Georg 2 ; Elsheikh Randa 3 ; Hirschman, Michael 4 ; Mengis Natalie 5 

 Department of Orthopedic Surgery and Traumatology, Kantonsspital Baselland, Bruderholz, CHE, Department of Clinical Research, Research Group Michael T. Hirschmann, Regenerative Medicine and Biomechanics, University of Basel, Basel, CHE 
 Department of Medicine and Infectious Diseases Service, Kantonsspital Baselland, Bruderholz, CHE 
 Department of Orthopedics and Traumatology, Kantonsspital Baselland, Bruderholz, CHE, Department of Clinical Research, Research Group Michael T. Hirschmann, Regenerative Medicine and Biomechanics, University of Basel, Basel, CHE 
 Department of Orthopedics and Traumatology, Kantonsspital Baselland, Bruderholz, CHE 
 Department of Clinical Research, University of Basel, Basel, CHE, Department of Orthopedic Surgery and Traumatology, Kantonsspital Baselland, Bruderholz, CHE 
University/institution
U.S. National Institutes of Health/National Library of Medicine
Publication year
2025
Publication date
2025
Publisher
Springer Nature B.V.
e-ISSN
21688184
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3234800998
Copyright
Copyright © 2025, Saner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.